Melodiol Global Health (Melodiol Global Health) FCF Margin % : -20.82% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Melodiol Global Health FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Melodiol Global Health's Free Cash Flow for the six months ended in Dec. 2023 was $-1.66 Mil. Melodiol Global Health's Revenue for the six months ended in Dec. 2023 was $7.98 Mil. Therefore, Melodiol Global Health's FCF Margin % for the quarter that ended in Dec. 2023 was -20.82%.

As of today, Melodiol Global Health's current FCF Yield % is -275.02%.

The historical rank and industry rank for Melodiol Global Health's FCF Margin % or its related term are showing as below:

COPHF' s FCF Margin % Range Over the Past 10 Years
Min: -32125 Med: -391.57 Max: -44.68
Current: -44.71

During the past 8 years, the highest FCF Margin % of Melodiol Global Health was -44.68%. The lowest was -32125.00%. And the median was -391.57%.

COPHF's FCF Margin % is ranked worse than
84.42% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.2 vs COPHF: -44.71

Melodiol Global Health FCF Margin % Historical Data

The historical data trend for Melodiol Global Health's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health FCF Margin % Chart

Melodiol Global Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-372.61

-410.63

-367.18

-203.17

-44.68

Melodiol Global Health Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial										-274.96	-143.77	-261.83	-85.32	-20.82

Competitive Comparison of Melodiol Global Health's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Melodiol Global Health's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's FCF Margin % falls into.

Melodiol Global Health FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Melodiol Global Health's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-5.659	/	12.665
	=	-44.68 %

Melodiol Global Health's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.662	/	7.983
	=	-20.82 %

Melodiol Global Health FCF Margin % Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Melodiol Global Health (Melodiol Global Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (OTCPK:COPHF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

ME1:Australia

Address

145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009

Website

https://www.cresopharma.com

Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (Melodiol Global Health) Headlines

From GuruFocus

Sierra Sage Herbs Acquired By Creso Pharma

By PRNewswire PRNewswire • 02-07-2022

Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

By PRNewswire PRNewswire • 02-08-2023